Biohaven Ltd. (BHVN)
NYSE·Healthcare·Biotechnology
$14.45
-0.14%
Mkt Cap $2.29B
Analyst Ratings
Buy
5
Hold
2
Sell
1
Price Target (31 analysts)
$20.00
Range $11.00 – $30.00
Implied Upside
+38.5%
Consensus $20.00 vs current $14.45
NYSE·Healthcare·Biotechnology
$14.45
-0.14%
Mkt Cap $2.29B
Buy
5
Hold
2
Sell
1
Price Target (31 analysts)
$20.00
Range $11.00 – $30.00
+38.5%
Consensus $20.00 vs current $14.45